Celldex Therapeutics Stock Continues To Fall

Celldex Therapeutics, Inc. (CLDX) shares are trading more than 15 percent lower on Friday, continuing a decline since June 24. The U.S. major shares were trending down on the day. There were no corporate announcements on the day to influence the stock movement.

Currently, Celldex shares are at $22.86, down 15.21 percent from the previous close of $26.96 on a volume of 1,296,128. For the 52-week period, the shares have traded in a range of 19.85-$57.20 on average volume of 689,509.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT